Perturbation of the Human Microbiome as a Contributor to Inflammatory Bowel Disease
暂无分享,去创建一个
[1] A. Khoruts,et al. From stool transplants to next-generation microbiota therapeutics. , 2014, Gastroenterology.
[2] L. Beutin,et al. α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon , 2014, Gut.
[3] F. Seibold,et al. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. , 2014, Gastroenterology.
[4] Kori L Wallace,et al. Immunopathology of inflammatory bowel disease. , 2014, World journal of gastroenterology.
[5] G. Kaplan,et al. The Increasing Weight of Crohn's Disease Subjects in Clinical Trials: A Hypothesis-generatings Time-trend Analysis , 2013, Inflammatory bowel diseases.
[6] W. Petritsch,et al. Alteration of Intestinal Dysbiosis by Fecal Microbiota Transplantation Does not Induce Remission in Patients with Chronic Active Ulcerative Colitis , 2013, Inflammatory bowel diseases.
[7] Anders F. Andersson,et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section , 2013, Gut.
[8] C. Manichanh,et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.
[9] J. Lewis,et al. Analysis of the human gut microbiome and association with disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] Patrice D Cani. Gut microbiota and obesity: lessons from the microbiome. , 2013, Briefings in functional genomics.
[11] Amjad Ali,et al. Implications of the human microbiome in inflammatory bowel diseases. , 2013, FEMS microbiology letters.
[12] Stefanie Wache,et al. Evaluating the Quality of Colorectal Cancer Care across the Interface of Healthcare Sectors , 2013, PloS one.
[13] Petra F. G. Wolffs,et al. The human microbiome as a reservoir of antimicrobial resistance , 2013, Front. Microbiol..
[14] R. Hunt,et al. Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis , 2013, The American Journal of Gastroenterology.
[15] S. Mazmanian,et al. Disruption of the gut microbiome as a risk factor for microbial infections. , 2013, Current opinion in microbiology.
[16] J. Guzman,et al. Diet, Microbiome, and the Intestinal Epithelium: An Essential Triumvirate? , 2013, BioMed research international.
[17] Ateequr Rehman,et al. Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans , 2013, PloS one.
[18] F. Guarner,et al. Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission , 2013, Inflammatory bowel diseases.
[19] Xin Wang,et al. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. , 2013, Diagnostic microbiology and infectious disease.
[20] G. Gloor,et al. Microbial ecosystems therapeutics: a new paradigm in medicine? , 2013, Beneficial microbes.
[21] H. Schleibinger,et al. Maintaining health by balancing microbial exposure and prevention of infection: the hygiene hypothesis versus the hypothesis of early immune challenge. , 2013, The Journal of hospital infection.
[22] Richard T. Jaspers,et al. Attenuated Increase in Maximal Force of Rat Medial Gastrocnemius Muscle after Concurrent Peak Power and Endurance Training , 2013, BioMed research international.
[23] Elisabeth M. Bik,et al. Distinct Distal Gut Microbiome Diversity and Composition in Healthy Children from Bangladesh and the United States , 2013, PloS one.
[24] S. Ng,et al. Geographical variability and environmental risk factors in inflammatory bowel disease , 2013, Gut.
[25] Curtis Huttenhower,et al. A Guide to Enterotypes across the Human Body: Meta-Analysis of Microbial Community Structures in Human Microbiome Datasets , 2013, PLoS Comput. Biol..
[26] Brian C. Thomas,et al. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization , 2013, Genome research.
[27] Brandi L. Cantarel,et al. Integrated Metagenomics/Metaproteomics Reveals Human Host-Microbiota Signatures of Crohn's Disease , 2012, PloS one.
[28] Paul D. Cotter,et al. Nucleic acid-based approaches to investigate microbial-related cheese quality defects , 2012, Front. Microbio..
[29] A. Bitton,et al. Inflammatory bowel disease: a Canadian burden of illness review. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[30] Zhining Fan,et al. Should we standardize the 1,700-year-old fecal microbiota transplantation? , 2012, The American journal of gastroenterology.
[31] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[32] Timothy L. Tickle,et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.
[33] Shenglan Wang,et al. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease , 2012, Experimental and therapeutic medicine.
[34] George M. Weinstock,et al. Genomic approaches to studying the human microbiota , 2012, Nature.
[35] E. Dempsey,et al. High-Throughput Sequencing Reveals the Incomplete, Short-Term Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin , 2012, Antimicrobial Agents and Chemotherapy.
[36] S. Salminen,et al. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. , 2012, The American journal of clinical nutrition.
[37] M. Blaser,et al. Antibiotics in early life alter the murine colonic microbiome and adiposity , 2012, Nature.
[38] A. Andoh,et al. Terminal Restriction Fragment Length Polymorphism Analysis of the Gut Microbiota Profiles of Pediatric Patients with Inflammatory Bowel Disease , 2012, Digestion.
[39] Y. Sanz,et al. Bacteroides uniformis CECT 7771 Ameliorates Metabolic and Immunological Dysfunction in Mice with High-Fat-Diet Induced Obesity , 2012, PloS one.
[40] M. Neuman,et al. Inflammatory bowel disease: role of diet, microbiota, life style. , 2012, Translational research : the journal of laboratory and clinical medicine.
[41] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[42] T. Matsui,et al. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease , 2012, Journal of Gastroenterology.
[43] D. C. Cara,et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. , 2012, The Journal of nutritional biochemistry.
[44] J. Clemente,et al. Human gut microbiome viewed across age and geography , 2012, Nature.
[45] M. Blaser,et al. The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.
[46] L. McDonald,et al. Infection control in the multidrug-resistant era: tending the human microbiome. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] P. Gionchetti,et al. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease. , 2012, Gastroenterology.
[48] R. Curi,et al. Regulation of Inflammation by Short Chain Fatty Acids , 2011, Nutrients.
[49] P. François,et al. Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue , 2011, Front. Microbio..
[50] J. Clemente,et al. Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within Humans , 2011, Science.
[51] P. Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[52] A. Danoff,et al. Energy, evolution, and human diseases: an overview. , 2011, The American journal of clinical nutrition.
[53] P. Moayyedi,et al. Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis , 2011, The American Journal of Gastroenterology.
[54] Julian Parkhill,et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.
[55] P. Vandamme,et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.
[56] K. Rioux,et al. Influences of intestinal bacteria in human inflammatory bowel disease. , 2010, Infectious disease clinics of North America.
[57] C. Bernstein,et al. Association Between the Use of Antibiotics in the First Year of Life and Pediatric Inflammatory Bowel Disease , 2010, The American Journal of Gastroenterology.
[58] N. Socci,et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.
[59] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[60] J. Coffey,et al. Desulfovibrio Bacterial Species Are Increased in Ulcerative Colitis , 2010, Diseases of the colon and rectum.
[61] Michael A McGuckin,et al. Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.
[62] Henrik Svanström,et al. Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.
[63] E. Fattal,et al. Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[64] D. Relman,et al. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.
[65] Minsoo Kim,et al. Bacterial interactions with the host epithelium. , 2010, Cell host & microbe.
[66] J. Doré,et al. Intestinal Microbiota of 6-week-old Infants Across Europe: Geographic Influence Beyond Delivery Mode, Breast-feeding, and Antibiotics , 2010, Journal of pediatric gastroenterology and nutrition.
[67] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[68] R. Knight,et al. The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.
[69] W. Michalski,et al. Mycobacterium avium subspecies paratuberculosis in children with early‐onset Crohn's disease , 2009, Inflammatory bowel diseases.
[70] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[71] J. Pitout. IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora. , 2009, Current opinion in investigational drugs.
[72] Hilary G. Morrison,et al. Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation , 2009, Infection and Immunity.
[73] K. Hunt,et al. Coprophagy by the semi-habituated chimpanzees of Semliki, Uganda , 2008 .
[74] I. Kaji,et al. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[75] G. Radford-Smith,et al. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. , 2008, World journal of gastroenterology.
[76] M. Abreu,et al. TLR4 signalling in the intestine in health and disease. , 2007, Biochemical Society transactions.
[77] R. Playford,et al. NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease. , 2007, Journal of Crohn's & colitis.
[78] W. Chamberlin. Importance of the Australian Crohn's disease antibiotic study. , 2007, Gastroenterology.
[79] F. Guarner. Prebiotics in inflammatory bowel diseases , 2007, British Journal of Nutrition.
[80] W. Selby,et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.
[81] L. Peyrin-Biroulet,et al. Antimycobacterial therapy in Crohn's disease: game over? , 2007, Gastroenterology.
[82] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[83] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[84] S. Galandiuk,et al. Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.
[85] F. Theissig,et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon , 2006, Gut.
[86] Philippe Marteau,et al. Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[87] F. Bäckhed,et al. Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[88] T. Giese,et al. High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn’s disease , 2005, Gut.
[89] Clive M. Onnie,et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease , 2005, The Lancet.
[90] E. Cario. BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2 , 2005, Gut.
[91] J. Reimund,et al. Animal models of inflammatory bowel disease. , 2004, Journal of pharmacological and toxicological methods.
[92] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[93] T. Borody,et al. Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy , 2003, Journal of clinical gastroenterology.
[94] F. Haesebrouck,et al. Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria , 2003, Clinical Microbiology Reviews.
[95] A. Concha,et al. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. , 2002, The Journal of nutrition.
[96] H. Ogata,et al. Animal models of inflammatory bowel disease , 2002, Journal of Gastroenterology.
[97] R. Sartor,et al. Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice , 2002, Inflammatory bowel diseases.
[98] Jean-Frederic Colombel,et al. Adherent Invasive Escherichia coli Strains from Patients with Crohn's Disease Survive and Replicate within Macrophages without Inducing Host Cell Death , 2001, Infection and Immunity.
[99] G. Reid,et al. Can bacterial interference prevent infection? , 2001, Trends in microbiology.
[100] F. Shanahan,et al. Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice , 2001, Alimentary pharmacology & therapeutics.
[101] G. Jacobasch,et al. Dietary resistant starch and chronic inflammatory bowel diseases , 1999, International Journal of Colorectal Disease.
[102] K. Madsen,et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.
[103] M. Kagnoff,et al. Epithelial cells as sensors for microbial infection. , 1997, The Journal of clinical investigation.
[104] F. Carbonnel,et al. Effects of cigarette smoking on the long-term course of Crohn's disease. , 1996, Gastroenterology.
[105] S. Hanauer,et al. Double blind, placebo controlled trial of metronidazole in Crohn's disease. , 1991, Gut.
[106] D. P. Strachan,et al. Hay fever, hygiene, and household size. , 1989, BMJ.
[107] J. Bennet,et al. TREATMENT OF ULCERATIVE COLITIS BY IMPLANTATION OF NORMAL COLONIC FLORA , 1989, The Lancet.
[108] B. Huitfeldt,et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations. , 1982, Gastroenterology.
[109] B. Huitfeldt,et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result. , 1982, Gastroenterology.
[110] P. Guy. Coprophagy in the African elephant (Loxadonta africana Blumenbach) , 1977 .
[111] T. Jukes. Antibiotics in Animal Feeds and Animal Production , 1972 .
[112] S. Khanna,et al. A clinician's primer on the role of the microbiome in human health and disease. , 2014, Mayo Clinic proceedings.
[113] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[114] R. Farrell,et al. Interactions Between Diet and Gut Microbes in Inflammatory Bowel Disease , 2013 .
[115] A. Mizoguchi. Animal models of inflammatory bowel disease. , 2012, Progress in molecular biology and translational science.